InBody Co.,Ltd (KOSDAQ:041830)
South Korea · Delayed Price · Currency is KRW 28,650
+1,700 (6.31%)
Oct 31, 2025, 3:30 PM KST
InBody Co.,Ltd Market Cap
InBody Co.,Ltd has a market cap or net worth of 328.58 billion as of October 30, 2025. Its market cap has increased by 1.91% in one year.
Market Cap
328.58B
Enterprise Value
243.78B
Revenue
217.55B
Ranking
n/a
PE Ratio
11.18
Stock Price
28,650.00
Market Cap Chart
Since November 3, 2004, InBody Co.,Ltd's market cap has increased from 10.60B to 328.58B, an increase of 2,999.24%. That is a compound annual growth rate of 17.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 328.58B | 10.44% |
| Dec 30, 2024 | 297.52B | -9.91% |
| Dec 28, 2023 | 330.23B | 25.50% |
| Dec 29, 2022 | 263.14B | -12.74% |
| Dec 30, 2021 | 301.57B | 33.43% |
| Dec 30, 2020 | 226.02B | -28.16% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 38.62T |
| ALTEOGEN | 25.24T |
| SK Biopharmaceuticals | 8.88T |
| Yuhan | 8.68T |
| HLB Co., Ltd. | 6.38T |
| Peptron | 6.13T |
| PharmaResearch | 5.65T |